CE Credit Hours: 3.00 Continuing Education Credit Hours
CEU Course Description
The safe and effective use of antipsychotic medications for children and adolescents in the United States is a critical issue in mental health and substance use treatment. The goal of this intermediate level continuing education course, developed using information from Substance Abuse and Mental Health Services Administration (SAMSHA), is to provide centralized information that articulates the scope of available systems‐level strategies to promote antipsychotic best practice prescribing for youth. The course material provides background information on antipsychotic prescribing and use among young people and intends to inform public and private sector decision‐makers, prescribing clinicians, service providers, and youth and their families of the best available evidence and corresponding recommendations.
CEU Course Objectives
1. Evaluate the experiences of families and youth who are prescribed antipsychotic medications, national trends in antipsychotic medication prescribing over time, and the safety and efficacy of antipsychotic medication treatment.
2. Describe the six key principles for system-level strategies to promote antipsychotic medication oversight and best practice prescribing for youth.
3. Identify ways to engage youth and families in direct care, to improve organizational barriers and policy and to engage prescribing clinicians in making evidence-based decisions.
4. Determine how to best consider the needs of special populations at every stage of development, implementation, and evaluation of strategies for evidence‐based antipsychotic prescribing.
5. Summarize specific strategies to promote antipsychotic medication oversight and best practice prescribing.
6. Identify promising practices regarding prior authorization of antipsychotic medication for youth, the use of drug utilization reviews, elective psychiatric consultation, and shared decision-making.
7. Analyze the connection between antipsychotic medication treatment and shortages in availability of non‐pharmacological alternatives such as behavioral therapies, psychological therapies, and other psychosocial services.
8. Outline implications for research pertaining to the long‐term safety and efficacy of antipsychotic prescribing and the effectiveness of strategies to promote antipsychotic best practice prescribing.
Did you know you can now get UNLIMITED Continuing Education Credit Hours for only $95/year?
Click Here to learn more.
Course Date: 2019-05-01
Our courseware includes the text content found on our websites as well as video, audio, and exam questions that make up our courses. You can link to and access our courseware free of charge for personal use. You may not modify or redistribute our courseware under any circumstances.
Although we allow free access for personal use, you may not use our courseware for any commercial purposes without an agreement in place. This includes (but is not limited to) using our courseware for internal training, redistributing our courseware for sale, and copying all or parts of any of our courseware.
If you're interested in licensing our content for commercial purposes or have any other questions, please contact email@example.com.
We will disclose, in advance, any proprietary interest in any product, instrument, device, service, or material to be discussed during the learning event, as well as the source of any third-party compensation related to the presentation. This policy applies to both our organization and contractors. If such proprietary/financial interests exist, we will publish a disclaimer in marketing or instructional materials for a course.
No conflict of interest or relevant financial relationship was identified for this learning activity for individuals in a position to control content.
In order to view this course, you will need to be able to view a PDF document for the course material. If your device doesn't have the capability to view a PDF, you can click here to download Adobe Acrobat for free.
If you require ADA or other special needs accommodations, please contact us by email: firstname.lastname@example.org or by phone 1-800-413-3797, so arrangements can be made.
The board approval status information is provided based on our current understanding of the licensing agencies. Please note that it is the responsibility of each licensee to verify acceptance of our courses with their licensing agency.